Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
15 déc. 2023 16h15 HE
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., Dec. 15, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC QB: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...